ClinicalTrials.gg
CompletedNCT07311707Updated Dec 31, 2025

Primary Closure vs Open Technique for Pilonidal Sinus

An interventional study of Primary Suturing of Surgical Wound and Open Surgical Wound Management in Pilonidal Sinus Disease, Sacrococcygeal Pilonidal Sinus and Chronic Infected Sinus Tract, sponsored by Khyber Teaching Hospital. Completed at 1 site in Pakistan. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-12-31.

Sponsored by Khyber Teaching Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 5 months after the study started (first participant enrolled Jul 2023, registered Dec 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

The purpose of this randomized controlled trial is to compare two commonly used surgical techniques for the treatment of pilonidal sinus disease: excision with primary closure and excision with open (lay-open) technique. Pilonidal sinus disease is a chronic inflammatory condition of the natal cleft that causes pain, discharge, and functional discomfort, particularly in young adults.

The primary aim of the study is to evaluate whether excision followed by primary closure leads to faster wound healing compared to the open surgical technique. Secondary aims include comparing postoperative wound infection and recurrence rates between the two surgical approaches.

Eligible participants aged 20 to 50 years with uncomplicated pilonidal sinus disease will be randomly allocated to one of two treatment groups. All surgical procedures will be performed by an experienced surgical team at Khyber Teaching Hospital, Peshawar. Postoperative care and follow-up schedules will be standardized for all participants. Outcomes will be assessed during follow-up visits at 1 week, 3 weeks, and 12 weeks after surgery.

This study is intended to provide evidence to guide surgical decision-making and improve postoperative outcomes for patients with pilonidal sinus disease.

Read the detailed description

Background and Rationale

Pilonidal sinus disease is a chronic inflammatory condition that primarily affects the natal cleft region and is most commonly seen in young adults. The disease is characterized by pain, discharge, recurrent infection, and limitations in daily activities, resulting in a reduced quality of life. It is more frequently observed in males and in individuals with prolonged sitting habits, obesity, or excessive body hair.

The pathogenesis of pilonidal sinus disease is widely accepted to be acquired, involving the penetration of loose hairs into the skin of the natal cleft, followed by a foreign body reaction and secondary infection. Surgical management remains the definitive treatment option, aiming to excise diseased tissue, promote wound healing, minimize complications, and reduce recurrence.

Multiple surgical techniques have been described in the literature; however, there is no universally accepted standard approach. Excision with primary closure allows immediate wound closure and potentially faster recovery, while excision with open (lay-open) technique permits healing by secondary intention and may reduce recurrence in certain cases. Variability in outcomes reported across studies highlights the need for randomized controlled trials conducted within uniform clinical settings.

This study is designed to compare these two surgical techniques under standardized operative and postoperative conditions in order to evaluate their relative effectiveness.

Study Objectives

Primary Objective To compare wound healing time between excision with primary closure and excision with open (lay-open) technique in patients with pilonidal sinus disease.

Secondary Objectives To compare the frequency of postoperative wound infection between the two surgical techniques.

To compare the rate of recurrence within the follow-up period between the two surgical techniques.

Study Design This study is a single-center, parallel-group, randomized controlled trial conducted at the Department of Surgery, Khyber Teaching Hospital, Peshawar, Pakistan. Participants will be randomly assigned in a 1:1 ratio to one of two intervention groups using a computer-generated block randomization method.

The study will be conducted in accordance with institutional ethical guidelines, and written informed consent will be obtained from all participants prior to enrollment.

Study Population Adult male and female patients aged 20 to 50 years diagnosed with uncomplicated pilonidal sinus disease will be assessed for eligibility.

Eligibility criteria, outcome measures, and follow-up schedules are defined in their respective sections of the record and are not duplicated here.

Sample Size and Sampling Technique A total sample size of 132 participants (66 per group) was calculated using the WHO sample size calculator, assuming a 95% confidence level, 80% power, and reference values from previously published studies. Eligible patients meeting inclusion criteria will be recruited using a non-probability consecutive sampling technique until the required sample size is achieved.

Randomization and Allocation Participants will be randomly allocated to one of the two study groups using computer-generated block randomization. Allocation concealment will be ensured through sealed opaque envelopes opened at the time of surgery.

Intervention Details All surgical procedures will be performed by the same surgical team with adequate experience to minimize inter-operator variability.

Group A: Excision with Primary Closure Complete excision of the pilonidal sinus tract will be performed, followed by primary wound closure using sutures after achieving adequate hemostasis.

Group B: Excision with Open (Lay-Open) Technique The pilonidal sinus tract and surrounding affected tissue will be excised, and the wound will be left open to heal by secondary intention with regular postoperative dressings.

All participants will receive standardized postoperative care, including wound dressing protocols, sitz baths, and antibiotic prophylaxis as per institutional guidelines.

Follow-up and Outcome Assessment

Participants will be evaluated postoperatively at:

1 week 3 weeks 12 weeks

Assessments will focus on wound healing status, signs of infection, and clinical evidence of recurrence. Data will be recorded using a standardized proforma by the principal investigator.

Statistical Analysis Data analysis will be performed using SPSS version 22. Quantitative variables will be summarized as mean and standard deviation, while qualitative variables will be presented as frequencies and percentages. Appropriate statistical tests will be applied to compare outcomes between groups, and a p-value of less than 0.05 will be considered statistically significant.

Key Words Pilonidal sinus disease, Primary closure, Open surgical technique, Wound healing, Wound infection, Recurrence, Randomized controlled trial

02

Conditions studied

  • Pilonidal Sinus Disease
  • Sacrococcygeal Pilonidal Sinus
  • Chronic Infected Sinus Tract
  • Post-surgical Wound Healing

Keywords

  • Pilonidal Sinus
  • Primary Closure
  • Wound Healing
  • Randomized Controlled Trial
  • Surgical Site Infection
03

In context

Pilonidal Sinus

109 studies on the registry are indexed under Pilonidal Sinus; 32 are open to participants now.

This study's enrollment of 60 is below the median of 80 across 72 interventional studies indexed under Pilonidal Sinus.

Browse Pilonidal Sinus studies →

Lead sponsor

Khyber Teaching Hospital is the lead sponsor of 29 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male and female patients aged 20 to 50 years.

Clinically diagnosed with pilonidal sinus (persistent painful discharging wound in the buttock cleft for more than eight weeks, VAS >4).

Patients willing to provide written .

Exclusion criteria

Exclusion Criteria:

  • Pilonidal sinus located away from the midline coccyx.

Presence of abscess formation.

Patients with underlying conditions affecting wound healing (e.g., diabetes mellitus).

Recurrent pilonidal sinus.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Excision with Primary Closure

    Participants assigned to this arm will undergo complete surgical excision of the pilonidal sinus tract followed by primary closure of the wound using standard suturing techniques. All procedures will be performed by an experienced surgical team. Postoperative management will be standardized and will include routine wound care, sitz baths, and antibiotic prophylaxis according to institutional protocol. Participants will be followed postoperatively to assess wound healing progress, postoperative complications, and recurrence during scheduled follow-up visits.

    Procedure: Primary Suturing of Surgical Wound · Procedure: Open Surgical Wound Management

  • Experimental
    Excision with Open (Lay-Open) Technique

    Participants assigned to this arm will undergo complete surgical excision of the pilonidal sinus tract, with the wound left open to heal by secondary intention. Standard postoperative wound care will be provided, including regular dressings, sitz baths, and antibiotic prophylaxis according to institutional protocol. Participants will be monitored during follow-up visits to assess wound healing, postoperative complications, and recurrence.

    Procedure: Primary Suturing of Surgical Wound · Procedure: Open Surgical Wound Management

Interventions

  • ProcedurePrimary Suturing of Surgical Wound

    The surgical site will be closed immediately after surgery using standard suturing techniques to approximate wound edges. This is the conventional method for wound closure in this study.

  • ProcedureOpen Surgical Wound Management

    The surgical site will be managed using an open approach without primary closure, with standard postoperative wound care.

06

What researchers measure

Primary outcomes

  1. Mean Duration of Wound Healing After Surgery

    Time (in days) from surgical intervention to complete wound epithelialization, assessed at 1, 3, and 12 weeks postoperatively, comparing primary closure versus open surgical technique.

    Time frame: 12 weeks

07

Study locations

1 site
  • Wasim Khan
    Peshawar, 25000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2023 to primary completion in Dec 2023, 5 months.

Of 35 interventional studies with no phase under Pilonidal Sinus, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's 5 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 12, 2025
First posted
Dec 31, 2025
StartActual
Jul 1, 2023
Primary completionActual
Dec 31, 2023
CompletionActual
Dec 31, 2023
Last update
Dec 31, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07311707
Lead sponsor
Khyber Teaching Hospital
Responsible party
Dr Asghar Ali (Principal Investigator, Khyber Teaching Hospital) — Principal investigator
First posted
Dec 31, 2025
Start date
Jul 1, 2023
Primary completion
Dec 31, 2023
Completion
Dec 31, 2023
Last update
Dec 31, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion